Sort   by:  
 Page size 

Abstract

Background

The gut microbiota is a key regulator of host lipid metabolism. In indigenous pigs, variation in growth performance and intramuscular fat (IMF) deposition has been linked to microbiota-host interactions, yet the specific taxa and metabolites that govern host lipid ...

2025-09-20 | MTBLS13017 | MetaboLights

Introduction: The gut microbiota and its metabolites are implicated in atherosclerosis, but the specific effector molecules and their pathophysiological significance remain unclear.

Objectives: This study aimed to identify key atheroprotective microbial metabolites and to elucidate the mech...

2026-01-31 | MTBLS13620 | MetaboLights
The aim of this work was to assess the antibiofilm activity of Cell Free Supernatant (CFS) produced by Limosilactobacillus reuteri DSM 17938 versus biofilm-producer bacterial species of clinical relevance.
ORGANISM(S): Escherichia coli 
2025-06-09 | PXD035326 | Pride

Upon reaching an OD600 of 0.3, L.

reuteri cultures were treated with 100 µM TCA, HCA, or

TCDCA. For BSHs inhibition assays, additional wells were treated with 100 µM

HCA + GR7. Both negative control and MRS medium control groups were included.

Cultures were terminated at 7...

2025-07-04 | MTBLS12641 | MetaboLights
Recent functional genomics and genome-scale modeling approaches indicated that B12 production in Lactobacillus reuteri could be improved by medium optimization. Here we show that a series of systematic single amino acid omissions could significantly modulate the production of B12 from nearly undetec...
ORGANISM(S): Lactobacillus reuteri F275 
Limosilactobacillus reuteri Genome sequencing
Limosilactobacillus reuteri Genome sequencing
Limosilactobacillus reuteri Genome sequencing
Limosilactobacillus reuteri isolate:QS01 Genome sequencing
Limosilactobacillus reuteri Genome sequencing
Sort   by:  
 Page size